Novartis Investigative Site

Bursa 16059

0 studies enrolling now · 6 studies all time

What they study most

Acute Heart Failure, Asthma, Chronic Obstructive Pulmonary Disease (COPD), Chronic Plaque Type Psoriasis, Heart Failure With Preserved Ejection Fraction, Psoriasis

Studies at this site

• A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients — Completed
• Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma Treatment — Stopped early
• Study of Secukinumab With 2 mL Pre-filled Syringes — Completed
• Global Non-interventional Heart Failure Disease Registry — Stopped early
• Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis — Completed
• A Study to Assess the Efficacy, Safety and Tolerability of Once-daily (q.d.) QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) — Completed